Grup d’Estudi en Malalties Metabòliques Associades a la Insulin-Resistència (GEMMAIR)

MALALTIES METABÒLIQUES I NUTRICIÓ
OBJECTIUS

GEMMAIR té una llarga trajectòria en l’estudi de la fisiopatologia de l’obesitat i les malalties associades. Actualment, el grup centra principalment la seva recerca en l’estudi de l’hepatopatia grassa no alcohòlica i les seves comorbiditats, com són l’obesitat, la diabetis mellitus de tipus 2 i la síndrome metabòlica, amb la finalitat de definir nous mecanismes moleculars implicats en la malaltia, i trobar possibles biomarcadors i potencials dianes terapèutiques.

RESPONSABLES
  • Dra. Teresa Auguet Quintillà

  • PRESENTACIÓ
  • Línies de recerca
  • Membres del grup
  • Membres del grup
  • TRANSFERÈNCIA
  • CONTACTE
  • Projectes
  • Publicacions
  • Projectes
  • Difusió

El Grup d’Estudi en Malalties Metabòliques Associades a la Insulin-Resistència (GEMMAIR) és un grup de recerca clínica i bàsica format per un equip multidisciplinari. Aquest es compon de personal investigador mèdic i experimental que pertany a l’Hospital Universitari de Tarragona Joan XXIII i a l’Hospital Universitari Sant Joan de Reus: metges internistes, cirurgians, patòlegs, biòlegs moleculars i tècnics de laboratori.

GEMMAIR té una trajectòria de més de 25 anys d’experiència en l’estudi de malalties hepàtiques cròniques i de més de 15 anys en l’estudi de l’obesitat i les malalties associades. Tanmateix, GEMMAIR està acreditat com a grup consolidat per l’Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) des de l’any 2009 i és un grup de recerca reconegut per la Universitat Rovira i Virgili (URV).

GEMMAIR ha realitzar diverses col·laboracions en l’àmbit nacional i internacional; a més el grup té una gran vinculació amb l’àmbit acadèmic, donat que la major part dels membres del grup son professors de la URV. També s’hi han dut a terme un gran nombre de tesis doctorals i treballs de final de grau i de màster, pel que GEMMAIR, té experiència en la formació del personal investigador novell.

  • Estudi de citoquines i adipocitoquines en la fisiopatologia de l’obesitat, la síndrome metabòlica i la malaltia de fetge gras no alcohòlic (MFGNA).
  • Expressió gènica, factors transcripcionals i epigenètica en la MFGNA.
  • Estudi dels metabòlits derivats de la microbiota en la MFGNA.
  • Ciències òmiques (metabolòmica, miRNòmica i proteòmica) en el diagnòstic no invasiu de l’esteatohepatitis no alcohòlica.
  • Ciències òmiques (metabolòmica i proteòmica) en l’estudi de la placa arterial arterioscleròtica.
  • Biomarcadors pronòstics de la COVID-19 en pacients amb obesitat i/o síndrome metabòlica.
  • Malaltia tromboembòlica venosa.

    Assajos clínics:

  • A Phase IIb/III Randomized, Double-blind,Placebo-controlled Study to Evaluate the Safety and Efficacy of Cotadutide in Participants with Non-cirrhotic Non-Alcoholic
    Steatohepatitis with Fibrosis (D5671C00006). AstraZenecaAB. Desde 2022. IP: Dr. David Riesco

  • Phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy and safety of recombinant human plasma gelsolin (RHUPGSN) added to standard of care for treatment of subjects with severe covid-19 pneumonia.
    Desde 2020. IP: Dra. T. Auguet

  • Safety and efficacy of favipipravir in COVID-19 patients with pneumonia. A randomized, double blind, placebo controlled study (FAVID01-20-SP). Ferrer Internacional, S.A. Desde 2020. IP: Dra. T. Auguet

  • Title: PCC_01-25_AJUDES DE L'IISPV PER AL PROJECTE CIENTÍFIC COMÚ_BPA-MASLD: INVESTIGATING EXPOSURE TO BPA AND ITS ANALOGUES IN RELATION TO METABOLIC DYSFUNCTION AND LIVER DISEASE. – IPV25002S

    Funding entity: FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA PERE I VIRGILI

    Duration: 2025-2026

    Principal Investigator: AUGUET QUINTILLA, TERESA

  • Title: 2021 SGR 00030 GRUP DE RECERCA CONSOLIDAT (GRC) OPCIO RECONEIXEMENT SENSE FINANÇAMENT (VALIDACIO TECNICA) URV-IISPV – PV23063S

    Funding entity: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Duration: 2022-2025

    Principal Investigator: AUGUET QUINTILLA, TERESA

  • Title: DIGITAL DIABETES ASSISTANT (DIGIDIAB) – PV24098S

    Funding entity: EIT HEALTH E.V.

    Duration: 2024-2025

    Principal Investigator: AUGUET QUINTILLA, TERESA

  • Title: PI25/00239_PROYECTOS DE I+D+I EN SALUD. ENVEJECIMIENTO EPIGENETICO HEPATICO Y LA PROGRESION DE LA ENFERMEDAD HEPATICA ESTEATOSICA ASOCIADA A DISFUNCION METABOLICA: EVALUACION DE UNA DIETA LIBRE EN BPS – PV25155S

    Funding entity: INSTITUTO CARLOS III

    Duration: 2026-2028

    Principal Investigator: AUGUET QUINTILLA, TERESA

  • Title: AYUDAS A LA INVESTIGACION FEMI_EVALUACION DE LA EFICACIA DE UNA DIETA LIBRE DE BISFENOL A (BPA) Y SUS ANALOGOS EN UNA COHORTE DE PACIENTES CON ENFERMEDAD HEPATICA METABOLICA (MASLD) – PV25183S

    Funding entity: FUNDACION ESPAÑOLA DE MEDICINA INTERNA

    Duration: 2026-2028

    Principal Investigator: AUGUET QUINTILLA, TERESA

    Assessing digestion-induced transformations of microplastics and their implications for biological studies

    Uroz-Mas, C, Barrientos-Riosalido, A, Expósito, N, Clavero-Mestres, H, Auguet, T, Rovira, J, Beltrán-Debón, R. 01/09/2026

    Effects of Animal-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities: A Systematic Review of Randomized Controlled Trials (2020-2026).

    Jurek JM, Zablocka-Slowinska K, Pieczynska J, Lipert A, Clavero-Mestres H, Auguet T. 08/05/2026

    Platelet-Activating Factor Pathway in Women With Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity.

    Duran-Bertran J, Clavero-Mestres H, Mahmoudian R, Muñiz-Piera S, Aguilar C, Riesco D, Camaron J, Martínez S, Vives M, París M, Sabench F, Auguet T. 01/05/2026

    Impact of bariatric surgery on the gut microbiota and metabolomic profile of the enterohepatic axis in an experimental model of obesity.

    Homs E, Vives M, Torrell H, Castillo DD, Sánchez A, Sabench F. 01/04/2026

    Impact of bariatric surgery on gut microbiota and metabolomic profile of the enterohepatic axis in an experimental model of obesity

    Homs, E, Vives, M, Torrell, H, del Castillo, D, Sánchez, A, Sabench, F. 01/04/2026

    Significant Activity of Pytren-2Q, a 2-Quinoline Polyamine Compound, against High-Concern Human Pathogenic Fungi.

    Inclán M, Clares MP, Álvarez-Duarte E, Fernández-Silva F, Salas V, Guarro J, Chicote JU, Verdejo B, Delgado-Pinar E, García-España E, García-España A, Calvo E. 17/02/2026

    Exploring the Role of TAS2Rs in Obesity: Insights From Human and Rat Models

    Descamps-Solà, M, Jalsevac, F, Vilalta, A, Fontcuberta, M, Park, H, Aguilar, C, Auguet, T, Beltrán-Debón, R, Rodríguez-Gallego, E, Pinent, M, Terra, X, Ardévol, A. 01/01/2026

    sTREM2 evaluation in women with metabolic dysfunction-associated steatotic liver disease: Advancing diagnostic approaches for early MASH

    Mahmoudian, R, Clavero-Mestres, H, Rusu, EC, Arredondo-Prats, V, Aguilar, C, Chicote, JU, Martinez, S, Riesco, D, Bartra, E, Borras, AT, Sabench, F, Auguet, T. 01/11/2025

    A Combination of Lacticaseibacillus paracasei CECT 30660 and Bifidobacterium longum subsp. infantis CECT 7210 Cell-Free Supernatants Reduces LPS-Induced Preterm Birth and Systemic Inflammation in Pregnant Mice

    Quesada-Vázquez, S, García, MCD, Cifuentes-Orjuela, G, Antolín, A, Alcaide-Hidalgo, JM, Jiménez, J, Puiggròs, F, Caimari, A, Sabench, F, Del Bas, JM, Escoté, X, Moreno-Muñoz, JA. 31/10/2025

    Systematic Review of the Effects of Plant-Based Foods on Metabolic Outcomes in Adults with MASLD and Comorbidities Such as Obesity, Metabolic Syndrome, and Type 2 Diabetes

    Jurek, JM, Zablocka-Slowinska, K, Pieczynska, J, Mestres, HC, Auguet, T. 22/09/2025

    Development and Validation of the Psychometric Properties of the FitMIND Foundation Sweets Addiction Scale-A Pilot Study

    Choroszynski, M, Jurek, JM, Mizia, S, Hudaszek, K, Clavero-Mestres, H, Auguet, T, Siennicka, A. 12/06/2025

    Differential Expression of Lipid Metabolism Genes, CROT and ABCG1, in Obese Patients with Comorbid Depressive Disorder and Risk of MASLD

    Jurek, JM, Rusu, EC, Camaron, J, Clavero-Mestres, H, Aguilar, C, Riesco, D, Xifré, B, Chicote, JU, Martinez, S, Vives, M, Sabench, F, Auguet, T. 11/06/2025

    C-reactive protein as a predictor of complicated acute cholecystitis: A cohort study.

    Renau G, Abelló D, Sabench F, Doménech J, Sánchez A. 09/06/2025

    Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery.

    Rusu EC, Clavero-Mestres H, Sánchez-Álvarez M, Veciana-Molins M, Bertran L, Monfort-Lanzas P, Aguilar C, Camaron J, Auguet T. 01/06/2025

    Clinical presentation and prognosis of acute symptomatic pulmonary embolism in patients with concomitant upper-extremity versus lower-extremity deep vein thrombosis.

    Dubois-Silva Á, Bikdeli B, Jiménez D, Barbagelata-López C, Fernández-Capitán C, Skride A, Pham KQ, Porras JA, Pacheco-Gómez N, Monreal M. 20/05/2025

    Differential Profiles of Gut Microbiota-Derived Metabolites of Bile Acids and Propionate as Potential Predictors of Depressive Disorder in Women with Morbid Obesity at High Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease-A Pilot Study

    Jurek, JM, Xifré, B, Rusu, EC, Clavero-Mestres, H, Mahmoudian, R, Aguilar, C, Riesco, D, Chicote, JU, Martinez, S, Vives, M, Sabench, F, Auguet, T. 12/05/2025

    C-reactive protein as a predictor of complicated acute cholecystitis: A cohort study

    Renau, G, Abelló, D, Sabench, F, Doménech, J, Sánchez, A. 01/05/2025

    The Impact of Dietary Interventions on Metabolic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Comorbid Conditions, Including Obesity and Type 2 Diabetes

    Jurek, JM, Zablocka-Sowinska, K, Mestres, HC, Gutiérrez, LR, Camaron, J, Auguet, T. 03/04/2025

    Exploring the role of fatty acid esters of hydroxy fatty acids in metabolic dysfunction-associated steatotic liver disease in morbidly obese women.

    Bertran L, Rusu EC, Aguilar C, Auguet T, Richart C. 01/02/2025

    Circulating proteomic profiles in women with morbid obesity compared to normal-weight women

    Bertran, L, Rusu, EC, Guirro, M, Aguilar, C, Auguet, T, Richart, C. 06/01/2025

    Multi-omics profiling reveals altered mitochondrial metabolism in adipose tissue from patients with metabolic dysfunction-associated steatohepatitis

    Castañé, H, Jiménez-Franco, A, Hernández-Aguilera, A, Martínez-Navidad, C, Cambra-Cortés, V, Onoiu, AI, Jiménez-Aguilar, JM, Paris, M, Hernández, M, Parada, D, Guilarte, C, Zorzano, A, Hernández-Alvarez, MI, Camps, J, Joven, J. 01/01/2025

    Results of the national registry of patients diagnosed with inflammatory bowel disease candidates for bariatric surgery (ReNacEIBar).

    Ferrer-Márquez M, Frutos Bernal MD, Ruiz de Gordejuela AG, García-Redondo M, Millán M, Sabench Pereferrer F, Tarascó Palomares J. 01/01/2024

    Metabolic adaptations in severe obesity: Insights from circulating oxylipins before and after weight loss

    Jiménez-Franco, A, Castañé, H, Martínez-Navidad, C, Placed-Gallego, C, Hernández-Aguilera, A, Fernández-Arroyo, S, Samarra, I, Canela-Capdevila, M, Arenas, M, Zorzano, A, Hernández-Alvarez, MI, Del Castillo, D, Paris, M, Menendez, JA, Camps, J, Joven, J. 01/01/2024

    Metabolic-Associated Fatty Liver Disease and Weight Loss After Bariatric Surgery: A Systematic Review and Meta-Analysis

    Sabench, F, Rusu, EC, Clavero-Mestres, H, Arredondo-Prats, V, Veciana-Molins, M, Muñiz-Piera, S, Vives, M, Aguilar, C, Bartra, E, París-Sans, M, Alibalic, A, Quintillà, MTA. 01/12/2024

    An Effective Liposome-Based Nanodelivery System for Naphthalene Derivative Polyamines with Antitumor Activity

    Pont, I, Felipe, R, Frias, JC, Chicote, JU, Garcia-Espana, A, Garcia-Espana, E, Albelda, MT. 01/11/2024

    Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction-associated steatotic liver disease

    Arto, C, Rusu, EC, Clavero-Mestres, H, Barrientos-Riosalido, A, Bertran, L, Mahmoudian, R, Aguilar, C, Riesco, D, Chicote, JU, Parada, D, Martinez, S, Sabench, F, Richart, C, Auguet, T. 01/11/2024

    Profiling bitter taste receptors (TAS2R) along the gastrointestinal tract and their influence on enterohormone secretion. Gender- and age-related effects in the colon

    Jalsevac, F, Descamps-Solà, M, Grau-Bové, C, Segú, H, Auguet, T, Avilés-Jurado, FX, Balaguer, F, Jorba, R, Beltrán-Debón, R, Blay, MT, Barbadora, XT, Pinent, M, Ardévol, A. 17/10/2024

    Towards understanding post-COVID-19 condition: A systematic meta-analysis of transcriptomic alterations with sex-specific insights.

    Rusu EC, Monfort-Lanzas P, Bertran L, Barrientos-Riosalido A, Solé E, Mahmoudian R, Aguilar C, Briansó S, Mohamed F, Garcia S, Camaron J, Auguet T. 01/06/2024

    Untargeted lipidomics analysis in women with morbid obesity and type 2 diabetes mellitus: A comprehensive study

    Bertran, L, Capellades, J, Abello, S, Aguilar, C, Auguet, T, Richart, C. 14/05/2024

    A prospective, randomized, blinded study on the efficacy of using corticosteroids in hydrodilatation as a treatment for adhesive capsulitis of the shoulder

    Gebellí-Jové, JT, Buñuel-Viñau, A, Canela-Capdevila, M, Camps, J, Sabench, F, Iftimie-Iftimie, P. 20/03/2024

    Platelet-associated biomarkers in nonalcoholic steatohepatitis: Insights from a female cohort with obesity

    Duran-Bertran, J, Rusu, EC, Barrientos-Riosalido, A, Bertran, L, Mahmoudian, R, Aguilar, C, Riesco, D, Martínez, S, Chicote, JU, Sabench, F, Richart, C, Auguet, T. 01/03/2024

    Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID).

    Horcajada JP, Aldonza R, Real M, Castañeda-Espinosa S, Sendra E, Gomez-Junyent J, López-Montesinos I, Gómez-Zorrilla S, Briansó S, Duran-Taberna M, Fernández A, Tarragó C, Auguet-Quintillá T. 25/02/2024

    Clinical and Biomarker Profile Responses to Rehabilitation Treatment in Patients with Long COVID Characterized by Chronic Fatigue

    Binetti, J, Real, M, Renzulli, M, Bertran, L, Riesco, D, Perpiñan, C, Mohedano, A, Segundo, RS, Ortiz, M, Porras, JA, Pineda, DR, Auguet, T. 01/07/2023

    LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity

    Bertran, L, Capellades, J, Abelló, S, Durán-Bertran, J, Aguilar, C, Martinez, S, Sabench, F, Correig, X, Yanes, O, Auguet, T, Richart, C. 01/06/2023

    LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus

    Auguet, T, Bertran, L, Capellades, J, Abelló, S, Aguilar, C, Sabench, F, Del Castillo, D, Correig, X, Yanes, O, Richart, C. 24/04/2023

    Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease

    Bertran, L, Adalid, L, Vilaró-Blay, M, Barrientos-Riosalido, A, Aguilar, C, Martínez, S, Sabench, F, Del Castillo, D, Porras, JA, Alibalic, A, Richart, C, Auguet, T. 01/04/2023

    The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease

    Barrientos-Riosalido, A, Bertran, L, Vilaró-Blay, M, Aguilar, C, Martínez, S, Paris, M, Sabench, F, Riesco, D, Binetti, J, Del Castillo, D, Richart, C, Auguet, T. 01/03/2023

    Increased Hepatic ATG7 mRNA and ATG7 Protein Expression in Nonalcoholic Steatohepatitis Associated with Obesity

    Barrientos-Riosalido, A, Real, M, Bertran, L, Aguilar, C, Martinez, S, Parada, D, Vives, M, Sabench, F, Riesco, D, Castillo, DD, Richart, C, Auguet, T. 10/01/2023

    Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis

    Castañe, H, Jiménez-Franco, A, Martínez-Navidad, C, Placed-Gallego, C, Cambra-Cortés, V, Perta, AM, París, M, Castillo, DD, Arenas, M, Camps, J, Joven, J. 01/12/2023

    Revisional bariatric surgery: On stage!

    Pereferrer, FS. 01/02/2023

    Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain.

    Roso-Llorach A, Serra-Picamal X, Cos FX, Pallejà-Millán M, Mateu L, Rosell A, Almirante B, Ferrer J, Gasa M, Gudiol C, Moreno AM, Morales-Rull JL, Rexach M, Sabater G, Auguet T, Vidal F, Lerida A, Rebull J, Khunti K, Argimon JM, Paredes R. 01/12/2022

    Rate of effect of surgical margins after breast conserving surgery and estimation of direct costs.

    Delgado C, Martínez S, Reig R. 01/11/2022

    Recent chromatographic and electrophoretic based methods for determining drugs of abuse in urine and oral fluid: A review from 2018 to June 2021

    Pascual-Caro, S, Borrull, F, Calull, M, Aguilar, C. 01/11/2022

    Rate of effect of surgical margins after breast conserving surgery and estimation of direct costs

    De la Flor, M, Delgado, C, Martínez, S, Arenas, M, Gómez, M, Reig, R. 01/11/2022

    Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?

    Auguet, T, Bertran, L, Barrientos-Riosalido, A, Fabregat, B, Villar, B, Aguilar, C, Sabench, F. 01/10/2022

    NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity

    Sabench, F, Bertran, L, Vives, M, París, M, Aguilar, C, Martínez, S, Binetti, J, Real, M, Alibalic, A, Richart, C, Del Castillo, D, Auguet, T. 01/10/2022

    Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

    Ceperuelo-Mallafré, V, Reverté, L, Peraire, J, Madeira, A, Maymó-Masip, E, López-Dupla, M, Gutierrez-Valencia, A, Ruiz-Mateos, E, Buzón, MJ, Jorba, R, Vendrell, J, Auguet, T, Olona, M, Vidal, F, Rull, A, Fernández-Veledo, S. 14/09/2022

    Increased Secreted Frizzled-Related Protein 5 mRNA Expression in the Adipose Tissue of Women with Nonalcoholic Fatty Liver Disease Associated with Obesity

    Bertran, L, Portillo-Carrasquer, M, Barrientos-Riosalido, A, Aguilar, C, Riesco, D, Martínez, S, Culebradas, A, Vives, M, Sabench, F, Del Castillo, D, Richart, C, Auguet, T. 01/09/2022

    Homemade Pipette Tip Solid-Phase Extraction for the Simultaneous Determination of 40 Drugs of Abuse in Urine by Liquid Chromatography-Tandem Mass Spectrometry

    Pascual-Caro, S, Borrull, F, Calull, M, Aguilar, C. 01/09/2022

    Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy

    Di Micco, P, Salazar, VR, Capitan, CF, Dentali, F, Cuervo, CG, Torres, JLF, Porras, JA, Fidalgo, A, Grandone, E, Meseguer, ML, Monreal, M. 01/08/2022

    New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease

    Bertran, L, Jorba-Martin, R, Barrientos-Riosalido, A, Portillo-Carrasquer, M, Aguilar, C, Riesco, D, Martínez, S, Vives, M, Sabench, F, Del Castillo, D, Richart, C, Auguet, T. 01/07/2022

    Laparoscopic Sleeve Gastrectomy in Patients with Severe Obesity Restores Adaptive Responses Leading to Nonalcoholic Steatohepatitis

    Cabré, N, Luciano-Mateo, F, Chapski, DJ, Baiges-Gaya, G, Fernández-Arroyo, S, Hernández-Aguilera, A, Castañé, H, Rodríguez-Tomàs, E, París, M, Sabench, F, Del Castillo, D, del Bas, JM, Tomé, M, Bodineau, C, Sola-García, A, López-Miranda, J, Martín-Montalvo, A, Duran, RV, Vondriska, TM, Rosa-Garrido, M, Camps, J, Menéndez, JA, Joven, J. 01/07/2022

    CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients

    López, C, Bosch, R, Korzynska, A, García-Rojo, M, Bueno, G, García-Fontgivell, JF, González, SM, Navarro, AG, Colón, ES, Ribes, JC, Roszkowiak, L, Mata, D, Arenas, M, Gómez, J, Roso, A, Berenguer, M, Reverté-Villarroya, S, Llobera, M, Baucells, J, Lejeune, M. 01/07/2022

    Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology

    Bertran, L, Eigbefoh-Addeh, A, Portillo-Carrasquer, M, Barrientos-Riosalido, A, Binetti, J, Aguilar, C, Chicote, JU, Bartra, H, Artigas, L, Coma, M, Richart, C, Auguet, T. 01/06/2022

    Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

    Trujillo-Santos, J, Farge-Bancel, D, Pedrajas, JM, Gómez-Cuervo, C, Ballaz, A, Braester, A, Mahé, I, Villalobos, A, Porras, JA, Monreal, M. 01/05/2022

    DigiPatICS: Digital Pathology Transformation of the Catalan Health Institute Network of 8 Hospitals-Planification, Implementation, and Preliminary Results

    Temprana-Salvador, J, López-García, P, Vives, JC, de Haro, L, Ballesta, E, Abusleme, MR, Arrufat, M, Marques, F, Casas, JR, Gallego, C, Pons, L, Mate, JL, Fernández, PL, López-Bonet, E, Bosch, R, Martínez, S, Cajal, SRY, Matias-Guiu, X. 01/04/2022

    High rate of de novo esophagitis 5 years after sleeve gastrectomy: a prospective multicenter study in Spain

    Ferrer, JV, Acosta, A, García-Alementa, EM, García, AT, Del Castillo, D, Espelta, MV, del Val, ID, Lacorzana, JO, González-Argente, FX, Pagan, A, Martínez, S, García, M, Mayo-Ossorio, MD, Morante, J, Moreno, JD, Isabial, SO, Picardo, A, Sánchez, JD, Sánchez, R, Pardellas, H, Vilallonga, R. 01/04/2022

    Development of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Determination of 40 Drugs of Abuse in Human Urine: Application to Real Cases

    Pascual-Caro, S, Borrull, F, Aguilar, C, Calull, M. 26/03/2022

    Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome

    Perpiñan, C, Bertran, L, Terra, X, Aguilar, C, Binetti, J, Lopez-Dupla, M, Rull, A, Reverté, L, Yeregui, E, Gómez-Bertomeu, F, Peraire, J, Auguet, T. 01/03/2022

    Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

    Bikdeli, B, Jimenez, D, Demelo-Rodriguez, P, Galeano-Valle, F, Porras, JA, Barba, R, Ay, C, Maly, R, Braester, A, Imbalzano, E, Rosa, V, Lecumberri, R, Siniscalchi, C, Fidalgo, A, Ortiz, S, Monreal, M. 01/02/2022

    Lipocalin, Resistin and Gut Microbiota-Derived Propionate Could Be Used to Predict Metabolic Bariatric Surgery Selected Outcomes

    Auguet, T, Lopez-Dupla, M, Ramos, J, Bertran, L, Riesco, D, Aguilar, C, Ardévol, A, Pinent, M, Sabench, F, Del Castillo, D, Richart, C. 01/01/2022

    Fetuin-A, inter-a-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

    Reverté, L, Yeregui, E, Olona, M, Gutiérrez-Valencia, A, Buzón, MJ, Martí, A, Gómez-Bertomeu, F, Auguet, T, López-Cortés, LF, Burgos, J, Benavent-Bofill, C, Boqué, C, García-Pardo, G, Ruiz-Mateos, E, Mestre, MT, Vidal, F, Viladés, C, Peraire, J, Rull, A. 01/01/2022

  • Títol: PCC_01-25_AJUDES DE L'IISPV PER AL PROJECTE CIENTÍFIC COMÚ_BPA-MASLD: INVESTIGATING EXPOSURE TO BPA AND ITS ANALOGUES IN RELATION TO METABOLIC DYSFUNCTION AND LIVER DISEASE. – IPV25002S

    Entitat finançadora: FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA PERE I VIRGILI

    Durada: 2025-2026

    Investigador principal: AUGUET QUINTILLA, TERESA

  • Títol: 2021 SGR 00030 GRUP DE RECERCA CONSOLIDAT (GRC) OPCIO RECONEIXEMENT SENSE FINANÇAMENT (VALIDACIO TECNICA) URV-IISPV – PV23063S

    Entitat finançadora: AGENCIA DE GESTIO D'AJUTS UNIVERSITARIS I DE RECERCA

    Durada: 2022-2025

    Investigador principal: AUGUET QUINTILLA, TERESA

  • Títol: DIGITAL DIABETES ASSISTANT (DIGIDIAB) – PV24098S

    Entitat finançadora: EIT HEALTH E.V.

    Durada: 2024-2025

    Investigador principal: AUGUET QUINTILLA, TERESA

  • Títol: PI25/00239_PROYECTOS DE I+D+I EN SALUD. ENVEJECIMIENTO EPIGENETICO HEPATICO Y LA PROGRESION DE LA ENFERMEDAD HEPATICA ESTEATOSICA ASOCIADA A DISFUNCION METABOLICA: EVALUACION DE UNA DIETA LIBRE EN BPS – PV25155S

    Entitat finançadora: INSTITUTO CARLOS III

    Durada: 2026-2028

    Investigador principal: AUGUET QUINTILLA, TERESA

  • Títol: AYUDAS A LA INVESTIGACION FEMI_EVALUACION DE LA EFICACIA DE UNA DIETA LIBRE DE BISFENOL A (BPA) Y SUS ANALOGOS EN UNA COHORTE DE PACIENTES CON ENFERMEDAD HEPATICA METABOLICA (MASLD) – PV25183S

    Entitat finançadora: FUNDACION ESPAÑOLA DE MEDICINA INTERNA

    Durada: 2026-2028

    Investigador principal: AUGUET QUINTILLA, TERESA

Membres De L’equip